目的：评价胰激肽原酶片治疗早期糖尿病肾病患者的疗效和安全性。
Objective: To evaluate the efficacy and safety of the pancreatic kininogenase tablets in treating early stage diabetic nephropathy.
目的系统观察参芪糖肾安汤治疗早期糖尿病肾病的临床疗效和安全性。
Objective: To systematically observe the clinical efficacy and security of Shen Qi Tang Shen an decoction in the treatment of early diabetic nephropathy.
糖尿病肾病患者每分钟尿白蛋白排泄率与ace和AT 1 R基因多态性无明显相关性。
In the DN group, the ACE genetype and AT1R genetype do not related with albumin excretion rate.
目的：观察低分子肝素钙对2型糖尿病肾病的疗效和安全性。
Objective: To observe the safety and efficacy of low molecular weight heparin calcic in treatment of type2 diabetic nephropathy.
方法：回顾性分析80例糖尿病肾病患者，按照入院时间先后将其分为对照组和观察组，每组各40例。
Methods: A retrospective analysis of 80 patients with diabetic nephropathy, who were divided into control group and observation group with 40 patients for each.
糖尿病可以导致严重的虚弱或致命性并发症，如心脏病，失明，肾病和截肢，在美国由于疾病一起的死亡中糖尿病是第5大主要病因。
Diabetes can lead to severely debilitating or fatal complications, such as heart disease, blindness, kidney disease, and amputations. It is the fifth leading cause of death by disease in the U. s.
方法对36例糖尿病肾病合并顽固性高血压患者随机分为治疗组和对照组，观察两组治疗前后降压情况、副作用和实验证据变化。
Methods There 36 diabetic nephropathy patients complicated with refractory hypertension were treated with two different therapies and the results were observed before and after the treatment.
方法对36例糖尿病肾病合并顽固性高血压患者随机分为治疗组和对照组，观察两组治疗前后降压情况、副作用和实验证据变化。
Methods There 36 diabetic nephropathy patients complicated with refractory hypertension were treated with two different therapies and the results were observed before and after the treatment.
应用推荐